(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202112 | 202012 | % Var | 202112 | 202012 | % Var | 202103 | 202003 | % Var | |
| Sales | 34796.00 | 34082.00 | 2.09 | 107365.00 | 99984.00 | 7.38 | 133491.00 | 118504.00 | 12.65 |
| Other Income | 630.00 | 628.00 | 0.32 | 3673.00 | 7341.00 | -49.97 | 8011.00 | 7432.00 | 7.79 |
| PBIDT | 6770.00 | 8368.00 | -19.10 | 22915.00 | 32534.00 | -29.57 | 39379.00 | 36128.00 | 9.00 |
| Interest | 77.00 | 65.00 | 18.46 | 253.00 | 298.00 | -15.10 | 467.00 | 478.00 | -2.30 |
| PBDT | 6693.00 | 8303.00 | -19.39 | 22662.00 | 32236.00 | -29.70 | 38912.00 | 35650.00 | 9.15 |
| Depreciation | 2054.00 | 2124.00 | -3.30 | 6091.00 | 6243.00 | -2.43 | 8350.00 | 7892.00 | 5.80 |
| PBT | 4639.00 | 6179.00 | -24.92 | 16571.00 | 25993.00 | -36.25 | 30562.00 | 27758.00 | 10.10 |
| TAX | 1228.00 | 1742.00 | -29.51 | 4536.00 | 7244.00 | -37.38 | 8698.00 | -1619.00 | -637.25 |
| Deferred Tax | 416.00 | 634.00 | -34.38 | 1584.00 | 2631.00 | -39.79 | 3297.00 | -6458.00 | -151.05 |
| PAT | 3411.00 | 4437.00 | -23.12 | 12035.00 | 18749.00 | -35.81 | 21864.00 | 29377.00 | -25.57 |
| Equity | 832.00 | 831.00 | 0.12 | 832.00 | 831.00 | 0.12 | 832.00 | 831.00 | 0.12 |
| PBIDTM(%) | 19.46 | 24.55 | -20.76 | 21.34 | 32.54 | -34.41 | 29.50 | 30.49 | -3.24 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1846.75 |
| Dr. Reddys Lab | 1276.05 |
| Cipla | 1335.00 |
| Zydus Lifesciences | 932.75 |
| Lupin | 2247.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: